On April 24, 2023 Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, reported that senior leadership plans to present at the following conferences (Press release, Iovance Biotherapeutics, APR 24, 2023, View Source [SID1234630434]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Chardan’s 7th Annual Genetic Medicine and Cell Therapy Manufacturing Summit
Fireside Chat: April 24, 2023 at 1:00 p.m. ET
Virtual
H.C. Wainwright BioConnect
Fireside Chat: May 2, 2023 at 11:30 a.m. ET
New York, NY
The JMP Securities Life Sciences Conference
Presentation: May 16, 2023 at 3:00 p.m. ET
New York, NY
The live and archived webcasts will be available at View Source